ROCHESTER, N.Y., Sept. 19, 2024—CooperVision announced today that Debbie Olive has been appointed Chief Commercial Officer. In her new role, Olive will oversee the company’s worldwide commercial functions, driving strategy and growth initiatives across the product portfolio. Succeeding Olive as President, Europe, Middle East, and Africa (EMEA), is Rodolphe Rota, who has been promoted from his previous role.
For over a decade, Olive has served in a variety of positions at CooperVision, from Vice President of Marketing for Europe to most recently President, EMEA. Under her leadership, the company has achieved record revenues, operating income, and market share in the region. Prior to joining CooperVision in 2013, Olive held senior sales and marketing roles at Novartis, Marks & Spencer, Kraft Jacob Suchard, and William Grant & Sons.
Since joining CooperVision as Vice President of Sales, EMEA, in 2022, Rota has leveraged his extensive commercial expertise to deliver outstanding performance across the region. More recently, he has overseen management of the company’s France, Iberia, and Italy markets. Rota previously spent nearly 30 years working in sales at Procter and Gamble, where he was named Vice President of European Sales, Oral Care.
“Both Debbie and Rodolphe have proven to be invaluable to CooperVision. Their strong leadership, depth of experience, and unwavering commitment to our mission of improving the way people see each day are critical to our success. I am confident that their contributions will help us continue to deliver exceptional value to our customers and partners around the world,” said Jerry Warner, President, CooperVision.
Olive reports to Warner and succeeds Mark Harty, who will retire in early 2025. Rota reports to Olive.
###
About CooperVision
CooperVision, a division of CooperCompanies (Nasdaq: COO), is one of the world’s leading manufacturers of contact lenses. The company produces a full array of daily disposable, two-week, and monthly soft contact lenses that feature advanced materials and optics, and premium rigid gas permeable lenses for orthokeratology and scleral designs. CooperVision has a strong heritage of addressing the toughest vision challenges such as astigmatism, presbyopia, childhood myopia, and irregular corneas; and offers the most complete portfolio of spherical, toric, and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com
About CooperCompanies
CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on improving lives one person at a time. The Company operates through two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, improving the vision of millions of people every day. CooperSurgical is a leading fertility and women’s health company dedicated to assisting women, babies, and families at the healthcare moments that matter most. Headquartered in San Ramon, Calif., CooperCompanies has a workforce of more than 15,000 with products sold in over 130 countries. For more information, visit www.coopercos.com
Media Contact
Heather Kowalczyk, APR
McDougall Communications for CooperVision
heather@mcdougallpr.com or 585-434-2148